Skip to main content
Premium Trial:

Request an Annual Quote

Arrowhead Releases HBV White Paper

Premium

Arrowhead Research this week released a white paper detailing the market potential for a hepatitis B therapy and the use of its dynamic polyconjugate siRNA-delivery technology to attack the virus.

The white paper can be found here.

"The development of a ... HBV candidate began under Roche and we are very pleased with the progress that our scientists have made," David Lewis, vice president of biology at Arrowhead, said in a statement.

He added that additional information about Arrowhead's HBV program, which was announced last month (GSN 2/16/2012), will be made public at upcoming scientific conferences and in peer-reviewed papers.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.